COVID-19 Drug Delivery Devices Market Size, Share, Trends, Growth 2032
COVID-19 Drug Delivery Devices Market By Product (Prefilled Syringes, Needle-Free Injectors, Inhalers, Patches, and Others), By Route of Administration (Parenteral, Nasal, and Dermal), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and by Region: Global Industry Perspective, Comprehensive Analysis and Forecast, 2020 - 2026
| Market Size in 2019 | Market Forecast in 2026 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 2,232.7 Million | USD 3,901.5 Million | 8.3% | 2019 |
The COVID-19 Drug Delivery Devices Market Size was worth around USD 2,232.7 Million in 2019 and is predicted to grow to around USD 3,901.5 Million by 2026 with a compound annual growth rate (CAGR) of roughly 8.3% between 2020 and 2026.
The report covers forecast and analysis for the COVID-19 drug delivery devices market on a global and regional level. The study provides historic data from 2016 to 2019 along with a forecast from 2020 to 2026 based on revenue (USD Million). The study includes drivers and restraints for the COVID-19 drug delivery devices market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the COVID-19 drug delivery devices market on a global as well as regional level.
In order to give the users of this report a comprehensive view on the COVID-19 drug delivery devices market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein product, route of administration, distribution channels, and regional segments are benchmarked based on their market size, growth rate and general attractiveness.
The report provides company market share analysis in order to give a broader overview of the key players in the COVID-19 drug delivery devices market. In addition, the report also covers key strategic developments of the market including acquisitions & mergers, new product launch, agreements, partnerships, collaborations & joint ventures, research& development, regional expansion of major participants involved in the COVID-19 drug delivery devices market on global and regional basis.
COVID-19 Drug Delivery Devices Market: Report Scope
| Report Attributes | Report Details |
|---|---|
| Report Name | COVID-19 Drug Delivery Devices Market Research Report |
| Market Size in 2019 | USD 2,232.7 Million |
| Market Forecast in 2026 | USD 3,901.5 Million |
| Growth Rate | CAGR of 8.3% |
| Number of Pages | 110 |
| Key Companies Covered | Bharat Biotech, Serum Institute of India, AstraZeneca, Johnson & Johnson, Pfizer, PharmaJet, Moderna, Novawax, Inc., and GlaxoSmithKline Plc |
| Segments Covered | By Product, By Route of Administration, By Distribution, And By Region |
| Regions Covered | North America, Europe, Asia Pacific (APAC), Latin America, Middle East, and Africa (MEA) |
| Base Year | 2019 |
| Historical Year | 2017 to 2019 |
| Forecast Year | 2020 - 2026 |
| Customization Scope | Avail customized purchase options to meet your exact research needs. Request For Customization |
The study provides a decisive view on the COVID-19 drug delivery devices market by segmenting the market based on the product, route of administration, distribution channel, and region. All the segments have been analyzed based on present and future trends and the market is estimated from 2016 to 2026. The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East and Africa.
Some of the leading players in the global market include
- Bharat Biotech
- Serum Institute of India
- AstraZeneca
- Johnson & Johnson
- Pfizer
- PharmaJet
- Moderna
- Novawax Inc.
- GlaxoSmithKline Plc
This report segments the global COVID-19 drug delivery devices market as follows:
By Product Analysis
- Prefilled Syringes
- Needle-Free Injectors
- Inhalers
- Patches
- Others
By Route of Administration Analysis
- Parenteral
- Nasal
- Dermal
By Distribution Channel Analysis
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
By Region Analysis
- North America
- The U.S.
- Canada
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
Table Of Content
Methodology
FrequentlyAsked Questions
According to the report, global demand for COVID-19 drug delivery devices market was valued at approximately USD 2,232.7 Million in 2019, and is expected to generate revenue of around USD 3,901.5 Million by end of 2026, growing at a CAGR of around 8.3% between 2020 and 2026.
Over the projected era, Asia Pacific is expected to experience a substantial CAGR as the region consists of emerging economies. Large population base, increased funding for research and exponential recorded cases of COVID-19 are expected to boost regional market growth.
The report includes detailed profiles of some of the players like Bharat Biotech, Serum Institute of India, AstraZeneca, Johnson & Johnson, Pfizer, PharmaJet, Moderna, Novawax, Inc., and GlaxoSmithKline Plc among others.
The Prefilled Syringe Segment is expected to account for the largest revenue share in the forecast period as the government organizations are making several efforts to increase prefilled syringe output.
Choose License Type
RelatedNews
Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651
3rd Floor,
Mrunal Paradise, Opp Maharaja Hotel,
Pimple Gurav, Pune 411061,
Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008
US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com
We have secured system to process your transaction.
Our support available to help you 24 hours a day, five days a week.
Monday - Friday: 9AM - 6PM
Saturday - Sunday: Closed